Celldex Therapeutics, Inc. - CLDX

Ownership (Schedule 13D / 13G) · latest 50 filings · Back to all files
Visible: 0
Filed Form Reporting person Percent Shares SEC
May 15, 2026 SCHEDULE 13G/A Kynam Capital Management, LP 8.77% 0 View
May 15, 2026 SCHEDULE 13G/A Kynam Capital Management GP, LLC 8.77% 0 View
May 15, 2026 SCHEDULE 13G/A Yue Tang 8.77% 0 View
May 15, 2026 SCHEDULE 13G/A Bellevue Group AG 1.5% 1,200,000 View
May 15, 2026 SCHEDULE 13G/A Bellevue Asset Management AG 1.5% 1,200,000 View
May 06, 2026 SCHEDULE 13G/A FMR LLC 5.6% 3,749,048 View
May 06, 2026 SCHEDULE 13G/A Abigail P. Johnson 5.6% 3,749,048 View
Apr 29, 2026 SCHEDULE 13G Vanguard Capital Management 5.17% 3,446,795 View
Mar 26, 2026 SCHEDULE 13G/A The Vanguard Group 0.0% 0 View
Mar 10, 2026 SCHEDULE 13G/A Point72 Asset Management, L.P. 2.6% 1,758,357 View
Mar 10, 2026 SCHEDULE 13G/A Point72 Capital Advisors, Inc. 2.6% 1,758,357 View
Mar 10, 2026 SCHEDULE 13G/A Steven A. Cohen 2.6% 1,758,357 View
Feb 10, 2026 SCHEDULE 13G/A Wellington Management Group LLP 12.2% 8,079,608 View
Feb 10, 2026 SCHEDULE 13G/A Wellington Group Holdings LLP 12.2% 8,079,608 View
Feb 10, 2026 SCHEDULE 13G/A Wellington Investment Advisors Holdings LLP 12.2% 8,079,608 View
Feb 10, 2026 SCHEDULE 13G/A Wellington Management Company LLP 11.8% 8,079,608 View
Feb 09, 2026 SCHEDULE 13G STATE STREET CORPORATION 5.1% 3,397,713 View
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G. Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F). Amendments (/A) can repeat the same holder over time, so rows should not be summed. Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.